Agena Biosciences MassArray System Cleared by China FDA
Oct 25, 2018 @ 11:28

Agena has an ongoing partnership with Guangzhou-based DaRui to develop MassArray-based diagnostics for cancer and inherited diseases for the Chinese market.

Sourced through Scoop.it from: www.genomeweb.com

Leave a Reply